Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

Name: Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
License: Public Domain

City of Hope Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

clear cell renal cell carcinoma, sarcomatoid renal cell carcinoma, stage ii renal cell cancer ajcc v8, stage iii renal cell cancer ajcc v8, stage iv renal cell cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 329521
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.